Chapter 1. GASTROINTESTINAL CANCER DEVICES MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. GASTROINTESTINAL CANCER DEVICES MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 - 2030
2.3.2. Impact on Supply – Demand
Chapter 3. GASTROINTESTINAL CANCER DEVICES MARKET – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. GASTROINTESTINAL CANCER DEVICES MARKET - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. GASTROINTESTINAL CANCER DEVICES MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. GASTROINTESTINAL CANCER DEVICES MARKET – By Product Type
6.1. Capsule Endoscopy
6.2. Endoscopic Ultrasound
6.3. Gi Videoscopes
6.4. Biopsy Devices
6.5. Endoscopic Retrograde Cholangiopancreatography Devices (ERCP)
6.6. Others
Chapter 7. GASTROINTESTINAL CANCER DEVICES MARKET – By End Use
7.1. Hospitals
7.2. Clinics
7.3. Others
Chapter 8. GASTROINTESTINAL CANCER DEVICES MARKET – By Region
8.1. North America
8.2. Europe
8.3. Asia-P2acific
8.4. Latin America
8.5. The Middle East
8.6. Africa
Chapter 9. GASTROINTESTINAL CANCER DEVICES MARKET – By Companies
9.1. Companies 1
9.2. Companies 2
9.3. Companies 3
9.4. Companies 4
9.5. Companies 5
9.6. Companies 6
9.7. Companies 7
9.8. Companies 8
9.9. Companies 9
9.10. Companies 10
2850
5250
4500
1800